Federated Hermes’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.1K Sell
3,186
-15
-0.5% -$76 ﹤0.01% 1744
2025
Q1
$20.7K Sell
3,201
-3,420
-52% -$22.2K ﹤0.01% 1719
2024
Q4
$48.6K Sell
6,621
-44,630
-87% -$328K ﹤0.01% 1674
2024
Q3
$384K Sell
51,251
-248,897
-83% -$1.86M ﹤0.01% 1377
2024
Q2
$2.67M Buy
300,148
+298,603
+19,327% +$2.66M 0.01% 857
2024
Q1
$15.7K Sell
1,545
-5,313
-77% -$53.8K ﹤0.01% 1746
2023
Q4
$69K Buy
+6,858
New +$69K ﹤0.01% 1614
2023
Q3
Sell
-1,140
Closed -$28K 2209
2023
Q2
$28K Sell
1,140
-946
-45% -$23.2K ﹤0.01% 1749
2023
Q1
$48.5K Buy
2,086
+286
+16% +$6.66K ﹤0.01% 1738
2022
Q4
$45.6K Sell
1,800
-236,113
-99% -$5.98M ﹤0.01% 1725
2022
Q3
$4.59M Buy
+237,913
New +$4.59M 0.01% 692
2022
Q2
Sell
-74
Closed -$2K 2288
2022
Q1
$2K Buy
+74
New +$2K ﹤0.01% 2039
2020
Q2
Sell
-26,058
Closed -$893K 2381
2020
Q1
$893K Buy
+26,058
New +$893K ﹤0.01% 1181